Acrospire Investment Management’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Acrospire Investment Management’s Portfolio IPCI Stock Details IPCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1,078	Closed	-$27K	–	2744
2017 Q1	$27K	Buy	1,078 +578	+116%	+$14.9K	0.02%	1438
2016 Q4	$14K	Buy	500 +350	+233%	+$9.78K	0.01%	1883
2016 Q3	$3K	Sell	150 -220	-59%	-$3.95K	﹤0.01%	1895
2016 Q2	$6K	Buy	370 +160	+76%	+$2.92K	﹤0.01%	1847
2016 Q1	$4K	Buy	+210	New	+$4.67K	﹤0.01%	1903

Other funds holding IPCI

FFA

First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ATC

Argent Trust Co Nashville, Tennessee $3.46B AUM 30.37% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 28.91% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Acrospire Investment Management's IPCI Position: Q2 2017 in Review

Acrospire Investment Management sold out of Intellipharmaceuticals International Inc. (IPCI) in Q2 2017, closing a stake of 1,078 shares — an estimated $27K sold.

Acrospire Investment Management first reported a position in IPCI in Q1 2016 and held it in 5 quarters. The position peaked at $27K in Q1 2017. 19 funds tracked by Wall St. Rank hold IPCI as of Q2 2017.

Acrospire Investment Management reported no remaining Intellipharmaceuticals International Inc. position as of Q2 2017 after selling out during the quarter.
Acrospire Investment Management sold 1,078 Intellipharmaceuticals International Inc. shares in Q2 2017, an estimated $27K.
Acrospire Investment Management first reported a position in Intellipharmaceuticals International Inc. in Q1 2016 and held it in 5 quarters.
Acrospire Investment Management's Intellipharmaceuticals International Inc. position peaked at $27K in Q1 2017.
19 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q2 2017.

Based on Acrospire Investment Management's 13F filing for Q2 2017, filed 11 Aug 2017.